Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Atea Pharmaceuticals (AVIR) Shares Issued (2020 - 2022)

Atea Pharmaceuticals has reported Shares Issued over the past 3 years, most recently at -$90000.0 for Q4 2022.

  • Quarterly results put Shares Issued at -$90000.0 for Q4 2022, down 163.38% from a year ago — trailing twelve months through Dec 2022 was $273000.0 (down 81.37% YoY), and the annual figure for FY2025 was $201000.0, down 24.72%.
  • Shares Issued for Q4 2022 was -$90000.0 at Atea Pharmaceuticals, down from $140000.0 in the prior quarter.
  • Over the last five years, Shares Issued for AVIR hit a ceiling of $317.6 million in Q4 2020 and a floor of -$90000.0 in Q4 2022.
  • Median Shares Issued over the past 3 years was $182500.0 (2021), compared with a mean of $39.9 million.
  • Peak annual rise in Shares Issued hit 52.65% in 2022, while the deepest fall reached 163.38% in 2022.
  • Atea Pharmaceuticals' Shares Issued stood at $317.6 million in 2020, then tumbled by 99.96% to $142000.0 in 2021, then plummeted by 163.38% to -$90000.0 in 2022.
  • The last three reported values for Shares Issued were -$90000.0 (Q4 2022), $140000.0 (Q3 2022), and $223000.0 (Q1 2022) per Business Quant data.